Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period

Blood Transfusion

Volumn 9, Issue 3, 2011, Pages 320-335

  Liumbruno, Giancarlo Maria ^a   Bennardello, Francesco ^b   Lattanzio, Angela ^c   Piccoli, Pierluigi ^d   Rossetti, Gina ^e  

^a SAN GIOVANNI CALIBITA FATEBENEFRATELLI HOSPITAL   (Italy)

^b CIVILE M P AREZZO HOSPITAL   (Italy)

^c Service of Immunohaematology and Transfusion Medicine   (Italy)

^d UNIVERSITY AND HOSPITAL TRUST OF VERONA   (Italy)

^e Trento Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; THROMBOCYTE CONCENTRATE;

ANEMIA; BLOOD AUTOTRANSFUSION; BLOOD COMPONENT; BLOOD SALVAGE; BLOOD TRANSFUSION; CARDIOVASCULAR SURGERY; ERYTHROCYTE CONCENTRATE; HEART SURGERY; HUMAN; HYPOXIA; ORTHOPEDIC SURGERY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREVALENCE; REVIEW;

ANEMIA; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; HUMANS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD;

EID: 79960668446     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2011.0076-10     Document Type: Review

References (210)

1. Corwin HL, Parsonnet KC, Gettinger A. RBC Transfusion in the ICU. Chest 1995; 108: 767-71.
2. von Ahsen N, Müller C, Serke S, et al. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med 1999; 27: 2630-9. (Pubitemid 30027173)
3. Rao MP, Boralessa H, Morgan C, et al. Blood component use in critically ill patients. Anaesthesia 2002; 57: 530-4. (Pubitemid 34649415)
4. Walsh TS, Lee RJ, Maciver CR, et al. Anemia during and at discharge from intensive care: the impact of restrictive blood transfusion practice. Intensive Care Med 2006; 32: 100-9. (Pubitemid 43039383)
5. Chohan SS, McArdle F, McClelland DBL, et al. Red cell transfusion practice following the transfusion requirements in critical care (TRICC) study: prospective observational cohort study in a large UK intensive care unit. Vox Sang 2003; 84: 211-8. (Pubitemid 36514178)
6. Vincent JL, Baron JF, Reinhart K, et al; ABC (Anemia and Blood Transfusion in Critical Care) Investigators. Anemia and blood transfusion in critically ill patients. JAMA 2002; 288: 1499-507.
7. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: anemia and blood transfusion in the critically ill: current clinical practice in the United States. Crit Care Med 2004; 32: 39-52.
8. Walsh TS, Saleh E, Lee RJ, et al. The prevalence and characteristics of anaemia at discharge home after intensive care. Intensive Care Med 2006; 32: 1206-13.
9. Napolitano LM. Scope of the problem: epidemiology of anemia and use of blood transfusions in critical care. Crit Care 2004; 8: S1-8.
10. McLellan SA, McClelland DB, Walsh TS. Anaemia and red blood cell transfusion in the critically ill patient. Blood Rev 2003; 17: 195-208. (Pubitemid 37356390)
11. Van de Wiel A. Anemia in critically ill patients. Eur J Inter Med 2004; 15: 481-6.
12. Martin J, Robitaille D, Perrault LP, et al. Reinfusion of mediastinal blood after heart surgery. J Thorac Cardiovasc Surg 2000; 120: 499-504.
13. Widman J, Jacobsson H, Larsson SA, Isacson J. No effect of drains on the postoperative hematoma volume in hip replacement surgery. Acta Orthop Scand 2002; 73: 625-9. (Pubitemid 36020904)
14. Esler CNA, Blakeway C, Fiddian NJ. The use of a closed-suction drain in total knee arthroplasty. J Bone Joint Surg Br 2003; 85: 215-7. (Pubitemid 36410543)
15. Johansson T, Engquist M, Pettersson LG, Lisander B. Blood loss after total hip replacement. A prospective randomized study between wound compression and drainage. J Arthroplasty 2005; 20: 967-71. (Pubitemid 41820980)
16. Parker MJ, Livingstone V, Clifton R, McKee A. Closed suction surgical wound drainage after orthopaedic surgery. Cochrane Database Syst Rev 2007; 3: CD001825.
17. Ezzie ME, Aberegg SK, O'Brien JM. Laboratory testing in the intensive care unit. Crit Care Clin 2007; 23: 435-65. (Pubitemid 47446141)
18. Chant C, Wilson G, Friedrich JO. Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study. Crit Care 2006; 10: R140.
19. Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 1994; 330: 377-81. (Pubitemid 24045653)
20. Pimentel M, Roberts DE, Bernstein CN, et al. Clinically significant gastrointestinal bleeding in critically ill patients in an era of prophylaxis. Am J Gastroenterol 2000; 95: 2801-6.
21. Lewis JD, Shin EJ, Metz DC. Characterization of gastrointestinal bleeding in severely ill hospitalized patients. Crit Care Med 2000; 28: 46-50. (Pubitemid 30091027)
22. Fisher L, Fisher A, Pavli P, Davis M. Perioperative acute upper gastrointestinal haemorrhage in older patients with hip fracture: incidence, risk factors and prevention. Aliment Pharmacol Ther 2007; 25: 297-308. (Pubitemid 46115399)
23. Levi M, Opal SM. Coagulation abnormalities in critically ill patients. Crit Care 2006, 10: 222.
24. Van Iperen CE, Gaillard CA, Kraaijenhagen RJ, et al. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med 2000; 28: 2773-8.
25. Krafte-Jacobs B. Anemia of critical illness and erythropoietin deficiency. Intensive Care Med 1997; 23: 137-8.
26. Rogiers P, Zhang H, Leeman M, et al. Erythropoietin response is blunted in critically ill patients. Intensive Care Med 1997; 23: 159-62. (Pubitemid 27110391)
27. Hobisch-Hagen P, Wiedermann F, Mayr A, et al. Blunted erythropoietic response to anemia in multiply traumatized patients. Crit Care Med 2001; 29: 743-7. (Pubitemid 32299710)
28. DeAngelo AJ, Bell DG, Quinn MV, et al. Erythropoietin response in critically ill mechanically ventilated patients: a prospective observational study. Crit Care 2005; 9: R172-6.
29. Corwin HL. The role of erythropoietin therapy in the critically ill. Transfus Med Rev 2006; 20: 27-33.
30. Biesma DH, Van de Wiel A, Beguin Y, et al. Post-operative erythropoiesis is limited by the inflammatory effect of surgery on iron metabolism. Eur J Clin Invest 1995; 25: 383-9.
31. Van Iperen CE, Kraaijenhagen RJ, Biesma DH, et al. Iron metabolism and erythropoiesis after surgery. Br J Surg 1998; 85: 41-5. (Pubitemid 28034109)
32. Rodriguez RM, Corwin HL, Gettinger A, et al. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care 2001; 16: 36-41. (Pubitemid 32207125)
33. Tabak C, Eugene J, Stemmer EA. Erythrocyte survival following extracorporeal circulation. A question of membrane versus bubble oxygenator. J Thorac Cardiovasc Surg 1981; 81: 30-3. (Pubitemid 11217342)
34. van Iperen CE, van de Wiel A, de Bruin M, Marx JJM. Total hip replacement surgery does not influence RBC survival. Transfusion 2000; 40: 1235-8.
35. Spahn DR, Casutt M. Eliminating blood transfusions. Anesthesiology 2000; 93: 242-55.
36. st ed. Bethesda, Maryland: AABB; 2006.
37. Goodnough LT, Shander A. Blood management. Arch Pathol Lab Med 2007; 131: 695-701. (Pubitemid 46726131)
38. World Health Organisation. The Clinical Use of Blood Handbook. Geneva: WHO; 2005.
39. Levy JH. Pharmacologic methods to reduce perioperative bleeding. Transfusion 2008; 48: 31S-38S.
40. Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: metaanalyses using perioperative blood transfusion as the outcome. Anesth Analg 1997; 85: 1258-67. (Pubitemid 28130521)
41. Wells PS. Safety and efficacy of methods for reducing perioperative allogeneic transfusion: a critical review of the literature. Am J Ther 2002; 9: 377-88.
42. Henry DA, Carless PA, Moxey AJ, et al. Antifibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2007; 4: CD001886.
43. Quenot JP, Thiery N, Barbar S. When should stress ulcer prophylaxis be used in the ICU? Curr Opin Crit Care 2009; 15: 139-43.
44. Cook DJ, Reeve BK, Guyatt G, et al. Stress ulcer prophylaxis in critically ill patients: resolving discordant meta-analyses. JAMA 1996; 275: 308-14.
45. Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med 1998; 338: 791-7. (Pubitemid 28135985)
46. Kantorova I, Svoboda P, Scheer P, et al. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology 2004; 51: 757-61. (Pubitemid 38590958)
47. Conrad SA, Gabrielli A, Margolis B, et al. Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med 2005; 33: 760-5.
48. Spirt MJ. Stress-related mucosal disease: risk factors and prophylactic therapy. Clin Ther 2004; 26: 197-213. (Pubitemid 38339012)
49. Pilon CS, Leathley M, Renne RRT, et al. Practice guideline for arterial blood gas measurement in intensive care unit decreases numbers and increases appropriateness of test. Crit Care Med 1997; 25: 1308-13. (Pubitemid 27347293)
50. Solomon DH, Hashimoto H, Daltroy L, et al. Techniques to improve physicians' use of diagnostic tests. JAMA 1998; 280: 2020-7.
51. Verstappen WHJM, van der Weijden T, Sijbrandij J, et al. Effect of a practice-based strategy on test ordering performance of primary care physicians. A randomized trial. JAMA 2003; 289: 2407-12. (Pubitemid 37430174)
52. Kumwilaisak K, Noto A, Schmidt UH, et al. Effect of laboratory testing guidelines on the utilization of tests and order entries in a surgical intensive care unit. Crit Care Med 2008; 36: 2993-9.
53. Kurz A. Thermal care in the perioperative period. Best Pract Res Clin Anaesthesiol 2008; 22: 39-62. (Pubitemid 351405122)
54. Beris P, Muñoz M, Erce JG, et al. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008; 100: 599-604. (Pubitemid 351774360)
55. Notebaert E, Chauny JM, Albert M, et al. Short-term benefits and risks of intravenous iron: a systematic review and meta-analysis. Transfusion 2007; 47: 1905-18. (Pubitemid 47440059)
56. Corwin HL, Gettinger A, Pearl RG, et al. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 2002; 288: 2827-35. (Pubitemid 35425068)
57. García-Erce JA, Cuenca J, Muñoz M, et al. Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study. Vox Sang 2005; 88: 235-43. (Pubitemid 40704896)
58. García-Erce JA, Cuenca J, Martinez F, et al. Perioperative intravenous iron preserve iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery. Transfus Med 2006; 16: 335-41. (Pubitemid 44453755)
59. Cuenca J, García-Erce JA, Martinez F, et al. Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery. Transfusion 2006; 46: 1112-9. (Pubitemid 44139484)
60. Karkouti K, McCluskey SA, Ghannam M, et al. Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. Can J Anaesth 2006; 53: 11-9. (Pubitemid 43230987)
61. Silver M, Corwin MJ, Bazan A, et al. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomised, double-blind, placebo-controlled trial. Crit Care Med 2006; 34: 2310-6. (Pubitemid 44260014)
62. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006; 105: 198-208.
63. Decreto del Ministro della Salute 3 Marzo 2005. Caratteristiche e modalità per la donazione di sangue e di emocomponenti. Gazzetta Ufficiale della Repubblica Italiana, n. 85 del 13 aprile 2005.
64. Council of Europe. Guide to the Preparation, Use and Quality Assurance of Blood Components. Recommendation No R (95) 15 on the Preparation, Use and Quality Assurance of Blood Components. 14th ed. Strasbourg: Council of Europe Press; 2008.
65. Società Italiana di Medicina Trasfusionale e Immunoematologia (SIMTI). Standard di Medicina Trasfusionale. 1a Ed. Milano: Edizioni SIMTI; 2007.
66. a Ed. Milano: Edizioni SIMTI; 2008.
67. Liumbruno G, Bennardello F, Lattanzio A, et al. Recommendations for the transfusion of red blood cells. Blood Transfus 2009; 7: 49-64.
68. Liumbruno G, Bennardello F, Lattanzio A, et al. Recommendations for the transfusion of plasma and platelets. Blood Transfus 2009; 7: 132-50.
69. Practice Guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996; 84: 732-47
70. Hebert PC, Hu LQ, Biro GP. Review of physiologic mechanisms in response to anemia. Can Med Assoc J 1997; 156: S27-40.
71. Hebert PC, Van der Linden P, Biro GP, Hu LQ. Physiologic aspects of anemia. Crit Care Clin 2004; 20: 187-212. (Pubitemid 38596811)
72. Hameed SM, Aird WC. Oxygen delivery. Crit Care Med 2003; 31: S658-67.
73. Ellis CG, Jagger J, Sharpe M. The microcirculation as a functional system. Crit Care 2005; 9: S3-8.
74. Wallis JP. Nitric oxide and blood: a review. Transfus Med 2005; 15: 1-11. (Pubitemid 40300002)
75. Carson JL, Hill S, Carless P, et al. Transfusion triggers: a systematic review of the literature. Transfus Med Rev 2002; 16: 187-99. (Pubitemid 34686541)
76. Siegemund M, van Bommel J, Ince C. Assessment of regional tissue oxygenation. Intensive Care Med 1999; 25: 1044-60. (Pubitemid 29525058)
77. Huang YC. Monitoring oxygen delivery in the critically ill. Chest 2005; 128: 554S-60.
78. Sehgal LR, Zelala RP, Takagi I, et al. Evaluation of oxygen extraction ratio as physiologic transfusion trigger in coronary artery bypass graft surgery patients. Transfusion 2001; 41: 591-5. (Pubitemid 32844997)
79. Spahn DR, Dettori N, Kocian R, Chassot PG. Transfusion in the cardiac patient. Crit Care Clin 2004; 20: 269-79. (Pubitemid 38596816)
80. Welte M, Hable O. Die indication zur perioperativen trasnfusion von erythrozyte. Anaesth Intensivmed 2005; 3: 73-83. (Pubitemid 40461572)
81. Madjdpour C, Marcucci C, Tissot JD, Spahn DR. Perioperative blood transfusion. Value, risks, and guidelines. Anaesthesist 2005; 54: 67-80.
82. Hill SR, Carless PA, Henry DA, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2002; 2: CD002042.
83. th ed. 2009. Available at: http://www.bundesaerztekammer.de/downloads/LeitCrossBloodComponents4ed.pdf. Last accessed on: 03/25/2010.
84. rd ed. New York, NY: Churchill Livingstone; 1996.
85. Murphy MF, Wallington TB, Kelsey P, et al; British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the clinical use of red cell transfusions. Br J Haematol 2001; 113: 24-31.
86. Clinical practice guidelines on the use of blood components (red blood cells, platelets, fresh frozen plasma, cryoprecipitate). Endorsed September 2001. National Health and Medical Research Council, Australasian Society of Blood Transfusion Inc. Available at: http://www.nhmrc.gov.au/publications/ synopses/-files/cp78.pdf. Last accessed on: 03/25/2010.
87. nd ed. American National Red Cross; 2007. Available at: http://www.redcross.org/ wwwfiles/Documents/WorkingWiththeRedCross/practiceguidelinesforbloodtrans.pdf. Last accessed on: 03/25/2010.
88. Agence française de sécurité sanitaire des produits de santé. Transfusion de globules rouges homologues: produits, indications, alternatives. Méthode générale et recommendations. Transfus Clin Biol 2002; 9: 333-56.
89. th ed. London, UK: TSO; 2007.
90. Scottish Intercollegiate Guidelines Network. Perioperative blood transfusion for elective surgery; October 2001. Available at: http://www.sign.ac.uk/pdf/sign54.pdf. Last accessed on: 03/25/2010.
91. McFarland JG. Perioperative blood transfusions: indications and options. Chest 1999; 115: S113-21.
92. Hebert PC, Wells G, Martin C, et al. Variation in red cell transfusion practice in the intensive care unit: a multicentre cohort study. Crit Care 1999; 3: 57-63. (Pubitemid 29272089)
93. Bracey AW, Radovancevic R, Riggs SA, et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion 1999; 39: 1070-7. (Pubitemid 29485322)
94. Hebert PC, Yetisir E, Martin C, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular disease? Crit Care Med 2001; 29: 227-34.
95. Wu WC, Rathore SS, Wang Y, et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001; 345: 1230-6. (Pubitemid 34951486)
96. Rao SV, Jollis JG, Harrington RA, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004; 292: 1555-62. (Pubitemid 39314961)
97. Hebert PC, Fergusson DA. Red blood cell transfusion in critically ill patients. JAMA 2002; 288: 1525-6.
98. Rao SV, Kaul PR, Liao L, et al. Association between bleeding, blood transfusion, and costs among patients with non ST-segment elevation acute coronary syndromes. Am Heart J 2008; 155: 369-74.
99. Murphy GJ, Reeves BC, Rogers PCA, et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007; 116: 2544-52. (Pubitemid 350179219)
100. Rao SV, Chiswell K, Sun JL, et al. International variation in the use of blood transfusion in patients with non ST-segment elevation acute coronary syndromes. Am J Cardiol 2008; 101: 25-9.
101. British Committee for Standards in Haematology. Guidelines for the use of platelet transfusions. Br J Haematol 2003; 122: 10-23.
102. Schiffer AC, Anderson KC, Bennet CL, et al. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19: 1519-38. (Pubitemid 32202560)
103. Bosly A, Muylle L, Noens L, et al. Guidelines for the transfusion of platelets. Acta Clin Belg 2007; 62: 36-47. (Pubitemid 46512949)
104. Tosetto A, Balduini CL, Cattaneo M, et al. Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res 2009, 124: e13-8.
105. Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 2009; 145: 24-33.
106. Searle E, Pavord A, Alfirevic Z. Recombinant factor VIIa and other pro-haemostatic therapies in primary postpartum haemorrhage. Best Pract Res Clin Obstet Gynaecol 2008; 22: 1075-88.
107. Hellem AJ, Borchgrevink CF, Ames SB. The role of red cells in haemostasis: the relation between haematocrit, bleeding time and platelet adhesiveness. Br J Haematol 1961; 7: 42-50.
108. Livio M, Gotti E, Marchesi D, et al. Uraemic bleeding: role of anemia and beneficial effect of red cell transfusions. Lancet 1982; 2: 1013-5. (Pubitemid 12035188)
109. Small M, Lowe GD, Cameron E, Forbes CD. Contribution of the haematocrit to the bleeding time. Haemostasis 1983; 13: 379-84.
110. Fernandez F, Goudable C, Sie P, et al. Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions. Br J Haematol 1985; 59: 139-48. (Pubitemid 15188829)
111. Escolar G, Garrido M, Mazzara R, et al. Experimental basis for the use of red cell transfusion in the management of anemic-thrombocytopenic patients. Transfusion 1988; 28: 406-11. (Pubitemid 18260642)
112. Burns ER, Lawrence C. Bleeding time. A guide to its diagnostic and clinical utility. Arch Pathol Lab Med 1989; 113: 1219-24.
113. Ho CH. The hemostatic effect of adequate red cell transfusion in patients with anemia and thrombocytopenia. Transfusion 1996; 36: 290.
114. Crowley JP, Metzger JB, Valeri CR. The volume of blood shed during the bleeding time correlates with the peripheral venous hematocrit. Am J Clin Pathol 1997; 108: 579-84. (Pubitemid 27459242)
115. Valeri CR, Cassidy G, Pivacek LE, et al. Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion 2001; 41: 977-83. (Pubitemid 33642786)
116. Eugster M, Reinhart WH. The influence of the hematocrit on primary haemostasis in vitro. Thromb Haemost 2005; 94: 1213-8. (Pubitemid 41819618)
117. Webert KE, Cook RJ, Sigouin CS, et al. The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia. Haematologica 2006; 41: 1530-7. (Pubitemid 44736120)
118. Webert KE, Cook RJ, Couban S, et al. A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation. Transfusion 2008; 48: 81-91.
119. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, et al; British Committee for Standards in Haematology. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126: 11-28. (Pubitemid 38859478)
120. Agence Française de Sécurité Sanitaire des Produits de Santé. Transfusion de plasma frais congelé: produits, indications, méthode général et recommandations. Transf Clin Biol 2002; 9: 322-32.
121. Hellstern P, Muntean W, Schramm W, et al. Practical guidelines for the clinical use of plasma. Thromb Res 2002; 95: 53-7.
122. Zimmerman JL. Use of blood products in sepsis: an evidence-based review. Crit Care Med 2004; 32: S542-7.
123. Levi M. Current understanding of disseminated intravascular coagulation. Br J Haematol 2004; 124: 567-76. (Pubitemid 38297089)
124. Williamson LM. Correcting haemostasis. Vox Sang 2004; 87: S51-7.
125. Gouezec H, Jego P, Betremieux P, et al. Indications for use of labile blood products and the physiology of blood transfusion in medicine. The French Agency for the Health Safety of Health Products. Transfus Clin Biol 2005; 12: 169-76. (Pubitemid 40805065)
126. Stanworth SJ, Brunskill SJ, Hyde CJ, et al. Appraisal of the evidence for the clinical use of FFP and plasma fractions. Best Pract Res Clin Haematol 2006; 19: 67-82. (Pubitemid 43118864)
127. British Committee for Standards in Hematology. Guidelines on the management of massive blood loss. Br J Haematol 2006; 135: 634-41.
128. Dzi k WH. The NHLBI Clinical Trials Network in transfusion medicine and hemostasis: an overview. J Clin Apher 2006; 21: 57-9.
129. Holland LL, Brooks JP. Toward rational fresh frozen plasma transfusion. Am J Clin Pathol 2006; 126: 133-9.
130. Stanworth SJ, Brunskill SJ, Hyde CJ, et al. Is fresh frozen plasma clinically effective? A systematic review of randomised controlled trials. Br J Haematol 2004; 126: 139-52. (Pubitemid 38859495)
131. Gajic O, Dzik WH, Toy P. Fresh frozen plasma and platelet transfusion for non bleeding patients in the intensive care unit: benefit or harm? Crit Care Med 2006; 34: S170-3.
132. Serious Hazards of Transfusion Annual Report 2008. The Serious Hazards of Transfusion Steering Group. Available at: http://www.shotuk.org/ SHOT%20Report%202008.pdf. Last accessed on: 03/25/2010.
133. Rapport Annuel Hémovigilance 2007. Agence francaise de sécurité sanitaire des produicts de santé. Available at: http://www.afssaps.fr/content/search?SearchText=hemovigilance. Last accessed on: 03/25/2010.
134. Madjdpour C, Spahn DR. Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications. Br J Anaesth 2005; 95: 33-42. (Pubitemid 40903884)
135. Shander A, Goodnough LT. Why an alternative to blood transfusion? Crit Care Clin 2009; 25: 261-77.
136. Bierbaum BE, Callaghan JJ, Galante JO, et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81: 2-10. (Pubitemid 29068441)
137. Carson JL, Altman DG, Duff A, et al. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999; 39: 694-700. (Pubitemid 29328481)
138. Carless PA, Henry DA, Moxey AJ, et al. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2006; 4: CD001888.
139. Sinardi D, Marino A, Chillemi S, et al. Composition of the blood sampled from surgical drainage after joint arthroplasty: quality of return. Transfusion 2005; 45: 202-7. (Pubitemid 40180136)
140. Davis RJ, Agnew DK, Shearly CR, et al. Erythrocyte viability in postoperative autotransfusion. J Pediatr Orthop 1993; 13: 781-3. (Pubitemid 23304745)
141. Ray JM, Flyn JC, Bierman AH. Erythrocyte survival following intraoperative autotransfusion in spinal surgery: an in vivo comparative study and 5-years update. Spine 1986; 11: 879-82. (Pubitemid 17012164)
142. Muñoz M, Garcia-Vallejo JJ, Ruiz MD, et al. Transfusion of post-operative shed blood: laboratory characteristics and clinical utility. Eur Spine J 2000; 13: S107-13.
143. Krohn CD, Reikeras O, Bjonsern S, Brosstad T. Tissue factor antigen and activity in serum of postoperatively shed blood used for autologous transfusion. Blood Coagul Fibrinolysis 2000; 11: 219-23. (Pubitemid 30331799)
144. Krohn CD, Reikeras O, Bjonsern S, Brosstad T. Fibrinolytic activity and postoperative salvaged untreated blood for autologous transfusion in major orthopaedic surgery. Eur J Surg 2001; 167: 168-72. (Pubitemid 32231952)
145. Arnestad JP, Bengtsson A, Bengtson JP, et al. Release of cytokines, polymorphonuclear elastase and terminal C5b-9 complement complex by infusion of wound drainage blood. Acta Orhop Scand 1995; 66: 334-8.
146. Dalen T, Bengtsson A, Brorsson B, Engstrom KG. Inflammatory mediators in autotransfusion drain blood after knee arthroplasty, with and without leucocyte reduction. Vox Sang 2003; 85: 31-9. (Pubitemid 36833200)
147. Krohn CD, Reikeras O, Molness TE. Complement activation and increased systemic and pulmonary vascular resistance indices during infusion of postoperatively drained untreated blood. Br J Anaesth 1999; 82: 47-51. (Pubitemid 29043127)
148. Amand T, Pincemail J, Blaffart F, et al. Levels of inflammatory markers in the blood processed by autotransfusion devices during cardiac surgery associated with cardiopulmonary bypass circuit. Perfusion 2002; 17: 117-23. (Pubitemid 34262795)
149. Muñoz M, Cobos A, Campos A, et al. Post-operative unwashed shed blood transfusion does not modify the cellular immune response to surgery for total knee replacement. Acta Anaesthesiol Scand 2006; 50: 443-50.
150. Hansen E, Hansen MP. Reason against the retransfusion of unwashed wound blood. Transfusion 2004; 44 (12 Suppl): 45S-53.
151. Keating EM, Meding JB. Perioperative blood management practices in elective orthopaedic surgery. J Am Acad Orthop Surg 2002; 10: 393-400.
152. Long GW, Glover JL, Bendick PJ, et al. Cell washing versus immediate reinfusion of intraoperatively shed blood during abdominal aortic repair. Am J Surg 1993; 166: 97-102. (Pubitemid 23280086)
153. Blaylock RC, Carlson KS, Morgan JM, et al. In vitro analysis of shed blood from patients undergoing total knee replacement surgery. Am J Clin Pathol 1994; 101: 365-9.
154. Southern EP, Huo MH, Mehta JR, Keggi KJ. Unwashed wound drainage blood: what are we giving our patients? Clin Orthop 1995; 320: 235-46.
155. Griffith LD, Billman GF, Daily PO, Lane TA. Apparent coagulopathy caused by infusion of shed mediastinal blood and its prevention by washing of the infusate. Ann Thorac Surg 1989; 47: 400-6. (Pubitemid 19100470)
156. Rubens FD, Boodhwani M, Lavalee G, Mesata T. Perioperative red blood cell salvage. Can J Anesth 2003; 50: S31-40.
157. Vertrees RA, Conti VR, Lick SD, et al. Adverse effects of postoperative infusion of shed mediastinal blood. Ann Thorac Surg 1996; 62: 717-23. (Pubitemid 26301764)
158. Dalrymple-Hay MJR, Dawkins S, Pack L, et al. Autotransfusion decreases blood usage following cardiac surgery: a prospective randomised trial. Cardiovasc Surg 2001; 9: 184-7. (Pubitemid 32201467)
159. Gardner A, Gibbs M, Evans C, Bell R. Relative cost of autologous red cell salvage versus allogeneic red cell transfusion during abdominal aortic aneurysm repair. Anaesth Intensive Care 2000; 28: 646-9. (Pubitemid 32007677)
160. Walpoth BH, Eggensperger N, Walpoth-Aslan BN, et al. Qualitative assessment of blood washing with the continuous autologous transfusion system (CATS). Int J Artif Organs 1997; 20: 234-9. (Pubitemid 27244550)
161. Huet C, Salmi LR, Fergusson D, et al. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. Anesth Analg 1999; 89: 861-9. (Pubitemid 29458457)
162. Muñoz M, Ariza D, Garceran MJ, et al. Benefits of postoperative shed blood reinfusion in patients undergoing unilateral total knee replacement. Arch Orthop Trauma Surg 2005; 125: 385-9. (Pubitemid 41102410)
163. Moonen AFCM, Knoors NT, van Os JJ, et al. Retransfusion of filtered shed blood in primary total hip and knee arthroplasty: a prospective randomized clinical trial. Transfusion 2007; 47: 379-84.
164. Munoz M, Kuhlmorgen B, Ariza D, et al. Which patients are more likely to benefit from postoperative shed blood salvage after unilateral total knee replacement? An analysis of 581 consecutive procedures. Vox Sang 2007; 92: 136-41. (Pubitemid 46239231)
165. Moonen AFCM, Thomassen BJW, van Os JJ, et al. Retransfusion of filtered shed blood in everyday orthopaedic practice. Transfus Med 2008; 18: 355-9.
166. Lorentz A, Osswald PM, Schilling M, Jani L. A comparison of autologous transfusion procedures in hip surgery. Anaesthesist 1991; 40: 205-13.
167. Slagis SV, Benjamin JB, Volz RG, Giordano GF. Postoperative blood salvage in total hip and knee arthroplasty. A randomised controlled trial. J Bone Joint Surg Br 1992; 74: 164-5.
168. Menges T, Rupp D, van Lessen A, Hempelmann G. Measures for reducing the use of homologous blood. Effects on blood coagulation during total endoprosthesis. Anaesthesist 1992; 41: 27-33.
169. Koopman-van Gemert AWMM. Processed autotransfusion and homologous red cell requirement in elective cardiac and orthopaedic surgery: a randomised prospective study. In: Perioperative Autotransfusion by Means of a Blood Cell Separator. Den Haag: Cip-Data Koninklijke Bibliotheek; 993. p. 105-26.
170. Mah ET, Davis R, Seshadri P, et al. The role of autologous blood transfusion in joint replacement surgery. Anaesth Intensive Care 1995; 23: 472-7.
171. Rollo VJ, Hozack WJ, Rothman RH, et al. Prospective randomised evaluation of blood salvage techniques for primary total hip arthroplasty. J Arthroplasty 1995; 10: 532-9.
172. Ekback G, Schott U, Axelsson K, Carberg M. Perioperative autotransfusion
173. Shenolikar A, Wareham K, Newington D, et al. Cell salvage autotransfusion in total knee replacement surgery. Transfus Med 1997; 7: 277-80. (Pubitemid 28051961)
174. Thomas D, Wareham K, Cohen D, Hutchings H. Autologous blood transfusion in total knee replacement surgery. Br J Anaesth 2001; 86: 669-73. (Pubitemid 32409409)
175. Clark CR, Spratt KF, Blondin M, et al. Perioperative autotransfusion in total hip and knee arthroplasty. J Arthroplasty 2006; 21: 23-35. (Pubitemid 43162982)
176. Majkowski RS, Currie IC, Newman JH. Postoperative collection and reinfusion of autologous blood in total knee arthroplasty. Ann R Coll Surg Engl 1991; 73: 381-4.
177. Gannon DM, Lombardi AV Jr, Mallory TH, et al. An evaluation of the efficacy of postoperative blood salvage after total joint arthroplasty. A prospective randomized trial. J Arthroplasty 1991; 6: 109-14.
178. Heddle NM, Brox WT, Klama LN, et al. A randomized trial on the efficacy of an autologous blood drainage and transfusion device in patients undergoing elective knee arthroplasty. Transfusion 1992; 32: 742-6.
179. Mauerhan DR, Nussman D, Mokris JG, Beaver WB. Effect of postoperative reinfusion systems on hemoglobin levels in primary total hip and total knee arthroplasties. A prospective randomized study. J Arthroplasty 1993; 8: 523-7. (Pubitemid 23306292)
180. Healy WL, Pfeifer BA, Kurtz SR, et al. Evaluation of autologous shed blood for autotransfusion after orthopaedic surgery. Clin Orthop 1994; 299: 53-9. (Pubitemid 24051699)
181. Riou B, Arock M, Guerrero M, et al. Haematological effects of postoperative autotransfusion in spinal surgery. Acta Anaesthesiol Scand 1994; 38: 336-41. (Pubitemid 24156128)
182. Rosencher N, Vassilieff V, Tallet F, et al. Comparison of Orth-Evac and Solcotrans Plus devices for the autotransfusion of blood drained after total knee joint arthroplasty. Ann Fr Anesth Reanim 1994; 13: 318-25.
183. Simpson MB, Murphy KP, Chambers HG, Bucknell AL. The effect of postoperative wound drainage reinfusion in reducing the need for blood transfusions in elective total joint arthroplasty: a prospective, randomized study. Orthopedics 1994; 17: 133-7. (Pubitemid 24064586)
184. Ayers DC, Murray DG, Duerr DM. Blood salvage after total hip arthroplasty. J Bone Joint Surg Am 1995; 77: 1347-51.
185. Rollo VJ, Hozack WJ, Rothman RH, et al. Prospective randomised evaluation of blood salvage techniques for primary total hip arthroplasty. J Arthroplasty 1995; 10: 532-9.
186. Newman JH, Bowers M, Murphy J. The clinical advantages of autologous transfusion: a randomised, controlled study after knee replacement. J Bone Joint Surg Br 1997; 79: 630-2.
187. Adalberth G, Bystrom S, Kolstad K, et al. Postoperative drainage of knee arthroplasty is not necessary: a randomised study of 90 patients. Acta Orthop Scand 1998; 69: 475-8. (Pubitemid 28534842)
188. Thurer RL, Lytle BW, Cosgrove DM, Loop FD. Autotransfusion following cardiac operations: a randomized, prospective study. Ann Thorac Surg 1979; 27: 500-7. (Pubitemid 9223875)
189. Dietrich W, Barankay A, Dilthey G, et al. Reduction of blood utilization during myocardial revascularization. J Thorac Cardiovasc Surg 1989; 97: 213-9. (Pubitemid 19061423)
190. Page R, Russell GN, Fox MA, et al. Hard-shell cardiotomy reservoir for reinfusion of shed mediastinal blood. Ann Thorac Surg 1989; 48: 514-7. (Pubitemid 19244694)
191. Eng J, Kay PH, Murday AJ, et al. Postoperative autologous transfusion in cardiac surgery: a prospective, randomised study. Eur J Cardiothorac Surg 1990; 4: 595-600.
192. Shirvani R. An evaluation of clinical aspects of post-operative autotransfusion, either alone or in conjunction with preoperative aspirin, in cardiac surgery. Br J Clin Pract 1991; 45: 105-18.
193. Lepore V, Radegran K. Autotransfusion of mediastinal blood in cardiac surgery. Scand J Thorac Cardiovasc Surg 1989; 23: 47-9. (Pubitemid 19034298)
194. Schönberger JP, Bredée J, Speekenbrink RG, et al. Autotransfusion of shed blood contributes additionally to blood saving in patients receiving aprotinin (2 million KIU). Eur J Cardiothorac Surg 1993; 7: 474-7.
195. Laub GW, Dharan M, Riebman JB, et al. The impact of intraoperative autotransfusion on cardiac surgery. A prospective randomized double-blind study. Chest 1993; 104: 686-9.
196. Ward HB, Smith RR, Landis KP, et al. Prospective, randomized trial of autotransfusion after routine cardiac operations. Ann Thorac Surg 1993; 56: 137-41. (Pubitemid 23227250)
197. Axford TC, Dearani JA, Ragno G, et al. Safety and therapeutic effectiveness of reinfused shed blood after open heart surgery. Ann Thorac Surg 1994; 57: 615-22. (Pubitemid 24114954)
198. Bouboulis N, Kardara M, Kesteven PJ, Jayakrishnan AG. Autotransfusion after coronary artery bypass surgery: is there any benefit? J Card Surg 1994; 9: 314-21. (Pubitemid 24178023)
199. Fragnito C, Beghi C, Cavozza C, et al. Autotransfusion of the blood drained from mediastinum in the course of myocardial revascularization. Acta Biomed Ateneo Parmense 1995; 66: 195-201.
200. Schmidt H, Mortensen PE, Folsgaard SL, Jensen EA. Autotransfusion after coronary artery bypass grafting halves the number of patients needing blood transfusion. Ann Thorac Surg 1996; 61: 1177-81. (Pubitemid 126336063)
201. Unsworth-White MJ, Kallis P, Cowan D, et al. A prospective randomised controlled trial of postoperative autotransfusion with and without a heparin-bonded circuit. Eur J Cardiothorac Surg 1996; 10: 38-47. (Pubitemid 126690691)
202. Zhao K, Xiao M, Deng S. Autotransfusion of shed mediastinal blood after open heart operation. Zhonghua Wai Ke Za Zhi 1996; 34: 497-9.
203. Dalrymple-Hay MJ, Pack L, Deakin CD, et al. Autotransfusion of washed shed mediastinal fluid decreases requirement for autologous blood transfusion following cardiac surgery: a prospective randomized trial. Eur J Cardiothorac Surg 1999; 15: 830-4. (Pubitemid 29331959)
204. Martin J, Robitaille D, Perrault LP, et al. Reinfusion of mediastinal blood after heart surgery. J Thorac Cardiovasc Surg 2000; 120: 499-504.
205. Naumenko SE, Pokrovskii MG, Belavin AS, Kim SF. Blood-saving effectiveness of preoperative reservation of autoblood for surgical treatment of ischaemic heart disease. Vestn Khir Im I I Grek 2003; 162: 59-64.
206. Zhao K, Xu J, Hu S, Wu Q, et al. Autotransfusion of shed mediastinal blood after open heart surgery. Chin Med J (Engl) 2003; 116: 1179-82. (Pubitemid 37069861)
207. Sowemino-Coker SO. Red blood cell hemolysis during processing. Transfus Med Rev 2002; 16: 46-60.
208. Spector JI, Crosby WH. Coagulation studies during experimental hemoglobinemia in humans. J Appl Physiol 1975; 38: 195-8.
209. Aaron RK, Beazley RM, Riggle GC. Hematologic integrity after intraoperative allotransfusion. Comparison with bank blood. Arch Surg 1974; 108: 831-7.
210. Zimmermann R, Heidenreich D, Weisbach V, et al. In vitro quality control of red blood cell concentrates outdated in clinical practice. Transfus Clin Biol 2003; 10: 275-83.